AN2 Therapeutics, Inc. (ANTX) — SEC filings
Recent SEC filings for AN2 Therapeutics, Inc. — 10-K, 10-Q, 8-K, proxy statements, and insider transactions.
| Form Type | Filing Date | Accepted Date |
|---|---|---|
| 8-K | 2026-06-09 | 2026-06-08 |
| 8-K | 2026-06-04 | 2026-06-04 |
| 4 | 2026-06-02 | 2026-06-02 |
| SC 13G/A | 2026-05-15 | 2026-05-15 |
| 10-Q | 2026-05-11 | 2026-05-11 |
| 8-K | 2026-05-11 | 2026-05-11 |
| ARS | 2026-04-22 | 2026-04-22 |
| DEFA14A | 2026-04-22 | 2026-04-22 |
| DEF 14A | 2026-04-22 | 2026-04-22 |
| EFFECT | 2026-04-20 | 2026-04-21 |
| 424B3 | 2026-04-20 | 2026-04-20 |
| 424B5 | 2026-04-20 | 2026-04-20 |
| 4 | 2026-04-10 | 2026-04-10 |
| 4 | 2026-04-10 | 2026-04-10 |
| 4 | 2026-04-10 | 2026-04-10 |
| S-3 | 2026-04-09 | 2026-04-09 |
| 8-K | 2026-04-09 | 2026-04-09 |
| D | 2026-03-25 | 2026-03-25 |
| 4 | 2026-03-23 | 2026-03-23 |
| 4 | 2026-03-23 | 2026-03-23 |
Recent SEC filings.